
IndraLab
Statements
reach
"We found that the broad-spectrum PTK inhibitor genistein (30 microM), the selective EGFR (epidermal growth factor receptor) kinase inhibitor AG556 (10 microM) and the Src family kinase inhibitor PP2 (10 microM) remarkably inhibited hERG channel current (I (hERG)), and the effects were significantly countered by the protein tyrosine phosphatase (PTP) inhibitor orthovanadate (1 mM)."